1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,081 | 0,125 | 30.12.25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | Circio Holding ASA Updated information to the notice of extraordinary general meeting 2025 | 2 | Oslo Børs | ||
| 23.12.25 | Correction: Circio Holding ASA Updated information to the notice of extraordinary general meeting 2026 | 1 | Oslo Børs | ||
| 19.12.25 | Circio Holding ASA Notice of extraordinary general meeting on 12 January 2026 | 1 | Oslo Børs | ||
| 08.12.25 | Circio Holding ASA Key information related to the rights issue | 3 | Oslo Børs | ||
| 08.12.25 | Circio Holding ASA: Circio announces 88% underwritten and presubscribed NOK 50 million rights issue with strong support from existing shareholders | 2 | Oslo Børs | ||
| 03.12.25 | Circio Holding ASA: Corr*: Atlas Holdings for CIRCIO | 2 | Oslo Børs | ||
| 03.12.25 | Circio Holding ASA: Atlas Holdings for CIRCIO | 8 | Oslo Børs | ||
| 24.11.25 | Circio Holding ASA: Circio presents data that further strengthens and broadens its circVec circular RNA expression platform | 2 | Oslo Børs | ||
| 19.11.25 | Circio Holding ASA: Atlas Holdings for CIRCIO | - | Oslo Børs | ||
| 19.11.25 | Circio Holding ASA: Shareholding Disclosure - Nordnet | 1 | Oslo Børs | ||
| 18.11.25 | Circio Holding ASA: Shareholding disclosure - Nordnet AB | 1 | Oslo Børs | ||
| 17.11.25 | Circio Holding ASA: Circio issues invitation to R&D and corporate update webcast on 24 November 2025 | 2 | Oslo Børs | ||
| 30.10.25 | Circio Holding ASA: Corr: Atlas Holdings for CIRCIO | 10 | Oslo Børs | ||
| 30.10.25 | Circio Holding ASA: Atlas Holdings for CIRCIO | 1 | Oslo Børs | ||
| 20.10.25 | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 1 | Oslo Børs | ||
| 15.10.25 | Circio Holding ASA: Requested Conversion of Convertible Bonds | 2 | Oslo Børs | ||
| 08.10.25 | Circio Holding ASA: Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025 | 3 | Oslo Børs | ||
| 06.10.25 | Circio Holding ASA: Requested Conversion of Convertible Bonds | 4 | Oslo Børs | ||
| 01.10.25 | Circio Holding ASA Approval and publication of prospectus for potential future share issues and conversion of convertible bonds | 3 | Oslo Børs | ||
| 01.10.25 | Circio Holding ASA: Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025 | 9 | Oslo Børs |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 5,450 | +0,26 % | Evotec-Aktie: Könnte schon bald die 0 Euro vorm Kurs stehen? | © Foto: fn SymbolbildDer Hamburger Biotech-Konzern Evotec taumelt. Die Aktie notiert noch knapp über der 5-Euro-Marke, aber nur wenige Cent vom Jahrestief entfernt. Gleichzeitig verkauft der Forschungsvorstand... ► Artikel lesen | |
| MEDIGENE | 0,022 | -11,81 % | Medigene: Gericht eröffnet Insolvenzverfahren | Bei Medigene geht die Insolvenz ihren Weg: Das zuständige Amtsgericht in München hat nach Angaben der Gesellschaft vom Freitag heute das Insolvenzverfahren über das Vermögen der Medigene AG sowie der... ► Artikel lesen | |
| VALNEVA | 3,762 | -0,27 % | Valneva Aktie: 2 Euro oder 8 Euro - wo liegen die nächsten Ziele? | Die Valneva Aktie hat turbulente Jahre mit einem Kurssturz auf 1,726 Euro hinter sich gebracht. Der Aktienkurs des französischen Impfstoff-Entwicklers befindet sich seit Ende 2024 aber wieder in einer... ► Artikel lesen | |
| NOVAVAX | 5,792 | +0,33 % | Novavax, Inc.: Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights | Total revenue of $70 million in the third quarter of 2025
Continued successful execution of Sanofi partnership with $225 million in milestones achieved year-to-date... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,510 | +2,03 % | INOVIO Pharmaceuticals, Inc.: FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) | PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help... ► Artikel lesen | |
| INFLARX | 0,851 | +1,31 % | InflaRx N.V.: InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum | While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed)... ► Artikel lesen | |
| BAVARIAN NORDIC | 25,660 | +0,20 % | Bavarian Nordic A/S: Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees | COPENHAGEN, Denmark, December 18, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management... ► Artikel lesen | |
| VAXART | 0,280 | 0,00 % | Vaxart kündigt Mietvertrag für Hauptsitz vorzeitig und plant Umzug in South San Francisco | ||
| REDHILL BIOPHARMA | 1,030 | 0,00 % | RedHill Biopharma Ltd. - F-1, Registration statement for certain foreign private issuers | ||
| EMERGENT BIOSOLUTIONS | 10,285 | -1,01 % | Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site | GAITHERSBURG, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License... ► Artikel lesen | |
| TELIX PHARMACEUTICALS | 6,692 | +1,24 % | Berger Montague: TELIX PHARMACEUTICALS LTD. (TLX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action | Philadelphia, Pennsylvania--(Newsfile Corp. - December 29, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals... ► Artikel lesen | |
| SINOVAC BIOTECH | - | - | Sinovac Biotech Ltd. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 3,628 | +1,85 % | CytomX-Aktie nach +1.000% - was jetzt? | Unser Community-Dauerbrenner CytomX Therapeutics hat sich seit unserem letzten Update Anfang Oktober weiter hervorragend entwickelt, konnte sich innerhalb eines Jahres mittlerweile verzehnfachen. Ist... ► Artikel lesen | |
| AGENUS | 2,740 | +0,74 % | Agenus Inc.: Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances | France grants reimbursed access with patients having commenced treatment Two-year BOT/BAL survival presented at ESMO spanning more than five cancers in over 400 patients Phase 3 on... ► Artikel lesen | |
| NORTHWEST BIOTHERAPEUTICS | 0,206 | 0,00 % | Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility | BETHESDA, Md., Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax personalized immune therapies... ► Artikel lesen |
CIRCIO HOLDING ASA gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,089 Euro und damit -1,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIRCIO HOLDING ASA finden Sie auf Wallstreet Online.